Rspondin-Lgr Axis in Bone Regeneration
骨再生中的 Rspondin-Lgr 轴
基本信息
- 批准号:10260493
- 负责人:
- 金额:$ 76.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-10 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAttenuatedBMP2 geneBindingBone InjuryBone RegenerationBone callusCalvariaCell LineageCellsChondrocytesClinicalDataDefectDevelopmentEmbryoFamilyFamily memberFractureFracture HealingGPR4 geneGenesGoalsHandHistologyIn VitroIncidenceIndividualInjuryKnockout MiceLeadLeucine-Rich RepeatLigandsLimb DevelopmentLimb structureLoxP-flanked alleleMechanicsMesenchymalMesenchymal Stem CellsMesenchymeMineralsModelingMolecularMolecular AnalysisMusOsteoblastsOsteogenesisPathway interactionsPeriosteal CellPeriosteumPlayPositioning AttributeProcessPropertyProteinsPublic HealthPublishingReceptor SignalingRecombinantsRegulationReporterResearchRoleSignal TransductionSiteSkeletal DevelopmentTestingTherapeutic UsesTimeWNT Signaling Pathwaybasebonebone healingcraniofacialhealingin vivoinjuredlong bonemRNA ExpressionmicroCTmouse modelnovelnovel strategiesnovel therapeuticsosteoblast differentiationosteochondral tissueosteogenicosteoprogenitor cellpreventprogenitorprotein functionreceptorregenerative therapyrepairedresponseresponse to injuryskeletalstemstem cellstissue regeneration
项目摘要
There is an urgent clinical need to develop new therapeutics to promote bone regeneration. A
critical aspect of the bone healing process begins with the expansion of periosteal progenitors
that occurs immediately after injury and then the differentiation of these progenitors to bone
forming osteoblasts and chondrocytes, yet mechanisms that control skeletal progenitor/stem cell
activation, expansion, and differentiation in response to injury are poorly described. Our project
will study the role of the R-spondin (ligand) – Lgr (receptor) signaling axis in regulating these
progenitors and bone regeneration. R-spondins (roof plate specific spondin) are a family of four
secreted matricellular proteins (Rspo1-4) that bind to Leucine-rich repeat-containing G-protein
coupled receptors 4/5/6 (Lgrs). Rspo-Lgr interaction potentiate canonical Wnt pathway by
preventing the turnover of Wnt Frizzled receptors, and hence determines canonical Wnt
signaling levels. While canonical Wnt signaling is known to play an important role in bone
regeneration, very little research has explored positive modulators of Wnt signaling. In
particular, the requirement of Rspo-Lgr in the context of fracture healing has never been
examined due to lack of appropriate models. Our primary goal is to define the requirement of
Rspo2/3 and Lgr6 in mesenchymal progenitors in response to bone injury. We have defined
three specific aims to address this goal. In Aim1, we will use single and compound Rspo2 and
Rspo3 floxed mice crossed with an alphaSMACreERT2 mouse to disrupt the Rspo2/3 genes in
mesenchymal progenitors at the time of fracture. Bone healing will be assessed using microCT,
histology, molecular analysis, and mechanical testing. Alterations in canonical Wnt signaling
and osteogenic potential of Rspo2/3 deficient progenitors will be assessed. In Aim 2, Lgr6
knockout mice will be investigated for their bone healing properties using parameters similar to
Aim 1. In Aim 3, Rspo2 will be delivered to bone injury sites and the impact on BMP and Wnt
signaling, progenitor activation and differentiation, and bone healing assessed. Completion of
this project will identify the requirement of Rspo2/3-Lgr6 interaction in fracture healing and will
provide new therapeutic directions for enhancing bone healing.
临床上迫切需要开发新的治疗方法来促进骨再生。一
骨愈合过程的关键方面始于骨膜祖细胞的扩张
然后这些祖细胞分化成骨
形成成骨细胞和软骨细胞,但控制骨骼祖细胞/干细胞的机制
对损伤后的激活、扩张和分化的描述很少。我们的项目
将研究R-spondin(配体)- Lgr(受体)信号传导轴在调节这些过程中的作用。
祖细胞和骨再生。R-spondins(顶板特异性spondin)是一个四个家族
分泌的基质细胞蛋白(Rspo 1 -4),与富含亮氨酸的重复序列的G蛋白结合
偶联受体4/5/6(LGR)。Rspo-Lgr相互作用通过增强经典Wnt途径
阻止Wnt卷曲受体的周转,因此决定了典型的Wnt
信号水平。虽然已知典型的Wnt信号传导在骨骼中起重要作用,
再生,很少有研究探索Wnt信号传导的正调节剂。在
特别地,在骨折愈合的背景下对Rspo-Lgr的需求从未被
由于缺乏合适的模型。我们的主要目标是定义
间充质祖细胞中的Rspo 2/3和Lgr 6对骨损伤的反应我们已经定义
三个具体目标来实现这一目标。在目标1中,我们将使用单个和复合Rspo 2,
Rspo 3 floxed小鼠与alphaSMACreERT 2小鼠杂交,以破坏细胞中的Rspo 2/3基因。
间充质祖细胞在骨折的时候。将使用microCT评估骨愈合,
组织学、分子分析和机械测试。经典Wnt信号传导的改变
并评估Rspo 2/3缺陷祖细胞的成骨潜力。在目标2中,Lgr 6
将使用类似于以下的参数研究敲除小鼠的骨愈合特性:
目标1.在目标3中,Rspo 2将被递送到骨损伤部位,并对BMP和Wnt的影响进行了研究。
信号传导、祖细胞活化和分化以及骨愈合。完成
本项目将确定骨折愈合中Rspo 2/3-Lgr 6相互作用的要求,并将
为促进骨愈合提供了新的治疗方向。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kurt David Hankenson其他文献
Kurt David Hankenson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kurt David Hankenson', 18)}}的其他基金
FASEB SRC: Matricellular Proteins: Fundamental Concepts and New Directions
FASEB SRC:基质细胞蛋白:基本概念和新方向
- 批准号:
10468385 - 财政年份:2022
- 资助金额:
$ 76.68万 - 项目类别:
ORS-ISFR 17th Biennial Conference: Thinking big on fracture repair
ORS-ISFR 第 17 届双年会:对骨折修复的大思考
- 批准号:
10066004 - 财政年份:2020
- 资助金额:
$ 76.68万 - 项目类别:
BMP6 Induction of Human Mesenchymal Stem Cell Osteoblast Differentiation
BMP6 诱导人间充质干细胞成骨细胞分化
- 批准号:
7436259 - 财政年份:2006
- 资助金额:
$ 76.68万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 76.68万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 76.68万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 76.68万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 76.68万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 76.68万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 76.68万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 76.68万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 76.68万 - 项目类别:
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 76.68万 - 项目类别:
Idea to Innovation
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 76.68万 - 项目类别:
Research Grant














{{item.name}}会员




